Recent years have witnessed remarkable developments in our understanding of pancreatic ductal adenocarcinoma, and many new concepts are beginning to be translated into novel therapeutic approaches. Though pancreatic cancer remains one of the deadliest cancers, work on the fundamental biological programs that drive the disease has yielded insights into the importance of stromal cells within the tumor, the behavior the neoplastic epithelial cells, and the paracrine signals that tie them together. This symposium will cover the latest research developments in pancreatic cancer, with a focus on preclinical and early clinical investigations of rationally targeted drugs that were translated from basic science observations.
Reception to follow
This event will also be broadcast as a webinar.
Please note: Transmission of presentations via the webinar is subject to individual consent by the speakers. Therefore, we cannot guarantee that every speaker's presentation will be broadcast in full via the webinar. To access all speakers' presentations in full, we invite you to attend the live event in New York City where possible.
|Nonmember (Student / Postdoc / Resident / Fellow)
Mission Partner support for the Frontiers of Science program provided by